641 filings
Page 2 of 33
8-K
7rd9w
9 Nov 23
TRACON Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
4:05pm
8-K
1anpruj1n nre40937sa
6 Oct 23
Departure of Directors or Certain Officers
5:00pm
8-K
dxod04
18 Sep 23
TRACON Pharmaceuticals Announces ENVASARC Phase 2 Pivotal Trial Exceeded Futility Threshold at Final Interim Analysis and Will Continue as Planned
8:10am
8-K
6xdorv3oca mv
7 Sep 23
Submission of Matters to a Vote of Security Holders
4:11pm
8-K
l0cvh
14 Aug 23
TRACON Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
4:12pm
8-K
jzc1cwpqrs et0e
11 Jul 23
TRACON Pharmaceuticals Announces Collection of Arbitration Award from I-Mab Biopharma
8:08am
8-K
v2n8 h8vzund1cg7
20 Jun 23
Single Agent Envafolimab ORR Exceeded Futility Rule that will be Applied at the Interim Efficacy Analysis Expected in Q3
8:08am
8-K
94488mkb5c8g9pv6
15 Jun 23
Other Events
8:08am
8-K
773c 10u7er84yegh
9 Jun 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
afkwrac
2 Jun 23
Unregistered Sales of Equity Securities
5:01pm
SC 13G
xo67p0oms38vuz41vz0
2 Jun 23
Tracon Pharmaceuticals / Lincoln Park Capital Fund ownership change
4:46pm
EFFECT
9224x 20dr4
1 Jun 23
Notice of effectiveness
12:15am
424B3
jddfh8r s7kv2td9l9wz
31 May 23
Prospectus supplement
4:21pm
UPLOAD
14mxexp
26 May 23
Letter from SEC
12:00am
CORRESP
g0p 5iff9
26 May 23
Correspondence with SEC
12:00am